Study title: “Observation of use/post-marketing surveillance: Efficacy and tolerance of Elacutan® cream at children with an age between 3 and 12 years having neurodermitis or ichthyosis.” (final report 07.05.2001)
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases [C08] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: CARBAMIDE | |||||
| ATC code: D02AE01 | |||||
| Document link: Elacutan Creme_Urea_AWB CVT0401_01_biometrical report.pdf | |||||
| Document date: 2011-09-28 | |||||
| Study number: CVT0401-01 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |